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Summary We have developed a new technique to measure in vivo tumour tissue fluid transport parameters (hydraulic conductivity and
compliance) that influence the systemic and intratumoral delivery of therapeutic agents. An infusion needle approximating a point source was
constructed to produce a radially symmetrical fluid source in the centre of human tumours in immunodeficient mice. At constant flow, the
pressure gradient generated in the tumour by the infusion of fluid (Evans blue-albumin in saline) was measured as a function of the radial
position with micropipettes connected to a servo-null system. To evaluate whether the fluid infused was reabsorbed by blood vessels,
infusions were also performed after circulatory arrest. In the colon adenocarcinoma LS174T with a spherically symmetrical distribution of
Evans blue-albumin, the median hydraulic conductivity in vivo and after circulatory arrest at a flow rate of 0.1 ,ul min-' was, respectively,
1 .7x10-7 and 2.3x10-7 cm2 mmHg-' s. Compliance estimates were 35 gl mmHg-' in vivo, and 100 ,ul mmHg-' after circulatory arrest In the
sarcoma HSTS 26T, hydraulic conductivity and compliance were not calculated because of the asymmetric distribution of the fluid infused.
The technique will be helpful in identifying strategies to improve the intratumoral and systemic delivery of gene targeting vectors and other
therapeutic agents.
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Systemic delivery oftherapeutic agents to solid tumours is gener-
ally hindered by vascular and interstitial barriers (Sands, 1992;
Jain, 1993). To circumvent these transport barriers, intratumoral
infusions or injections have received increasing interest in recent
years (Order et al, 1994; Viola et al, 1995; Heise et al, 1997;
Nomura et al, 1997). While the vascular barrier is circumvented by
this route, the interstitial matrix still poses a formidable barrier.
Key determinants for the success of intratumoral delivery include
the tissue hydraulic conductivity (K) and compliance (C).
However, there are presently no direct in vivo data for these two
parameters in solid tumours. The lack of such measurements is
mainly due to experimental difficulties.
In normal tissues, resistance to fluid flow is a function of the
concentration of interstitial matrix constituents (glycosaminogly-
cans and collagen content) and the degree of hydration of the
matrix (Swabb et al, 1974; Jain, 1987; Levick, 1987). K has been
estimated mostly under in vitro conditions and in a few studies in
vivo. In vitro, K is generally estimated by measuring the flow after
applying pressure across a tissue slice of known area and thick-
ness. In this case, hydration, slicing of the tissue and compression
are potential factors that can influence the determination of K. In
vivo estimates ofK are also not straightforward, because the char-
acterization of tissue dimensions can be difficult. Furthermore,
fluid reabsorption by blood vessels or lymphatics may result in an
overestimation ofK (Guyton et al, 1966; Levick, 1980; Netti et al,
1995). Also, K cannot be determined independently in the tran-
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sient state of infusion, because C is involved in the process. To
uncouple K from C, the measurements for K must be performed in
steady-state conditions (Swabb et al, 1974; Ford et al, 1991; Tokita
and Tanaka, 1991).
The goal of the present study was, therefore, to develop a new
technique to estimate K in solid tumours, in vivo, at steady state
and with a good spatial resolution. To this end, fluid (Evans
blue-albumin in saline) was infused at low flow rates into the
centre of a tumour with a special needle approximating a point
source. The pressure increased gradually during fluid infusion and
reached a plateau, indicating the attainment of steady state. At
steady state, the pressure was measured at known distances from
the source with a micropipette connected to a servo-null device. K
and C were estimated in tumours with a spherically symmetrical
distribution of the fluid infused as determined by the distribution
ofEvans blue albumin. In the sarcoma HSTS 26T, the distribution
ofEvans blue was asymmetric. Kand C were estimated in LS174T
following the confirmation of a spherically symmetrical fluid
distribution. C was estimated from the time constant required for
the equilibrium ofthe infusion pressure.
MATERIALS AND METHODS
Animals and tumours
Eight- to ten-week-old athymic NCr/Sed-nu/nu mice from the
Edward L Steele Laboratory animal facility were used. The mice
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Figure 1 A Schematic diagram of infusion needle. The needle was
constructed from a 22-gauge needle and a thin steel wire. The sharp tip of a
22-gauge needle was cut and glued to one end of the steel wire. The other
end of the steel wire was placed in the 22-gauge cylinder. A fixed opening of
approximately 0.7 mm was produced between the tip and cylinder by bending
the wire perpendicular to the main axis of the needle. PE 50 tubing was used
to stabilize the opening between the tip and cylinder, and for connection with
the infusion pump and pressure transducer. B Schematic diagram of the
experimental set-up. The point-source needle (1) was placed in the centre of
the tumour (radius R) and fluid infused at a constant flow rate. Steady-state
radial pressure profiles were measured with high spatial resolution using a
glass micropipette (2) in a region 0.3-2.0 mm from the edge of the infusion
needle (3)
were fed sterilized rodent food and water ad libitum. Two human
tumours, the colon adenocarcinoma LS174T and the sarcoma
HSTS 26T, were implanted subcutaneously in the leg of each
mouse. K was estimated when the tumours had reached a volume
between 200 and 500 mm3.
Infusion needle
To infuse fluid into the centre of a tumour, an infusion needle was
constructed to produce a spherically symmetrical fluid source
(Figure 1A). A very thin stainless-steel wire (35 mm long) was
fixed to the sharp portion (2 mm in length) of a 22-gauge needle
with epoxy glue. The other end of the wire was introduced in the
lumen of a 22-gauge cylinder. A fixed opening of approximately
0.7 mm in length between the sharp portion and the 22-gauge
cylinder was produced by bending the wire perpendicular to the
main axis of the needle. To fix the opening between the sharp
portion and the cylinder, PE-50 tubing was attached to the
cylinder. The needle and the PE 50 tubing were glued to a
Plexiglas arm mounted on a graded micromanipulator, which was
used for controlling the depth of needle insertion. To measure the
pressure of infusion, the needle was connected to the side port of
the dome of a pressure transducer (Statham 23b, Spectramed,
Oxnard, CA, USA) by the PE-50 tubing, and another side port on
the dome was connected by PE 50 tubing to a l-ml syringe
controlled by a constant flow infusion pump (Pump 22, Harvard
Apparatus, South Natick, MA, USA). The compliance ofthe pres-
sure transducer infusion pump setup was 0.04 ,ul mmHg-'.
Pressure measurements
The pressure was measured with micropipettes and a servo-null
device as previously described previously (Boucher et al, 1990;
Boucher and Jain, 1992). To prepare the micropipettes, thick-wall
capillary tubing (0.86 mm outer diameter, 0.38 mm inner diam-
eter) was pulled with a micropipette puller. Micropipettes with a
tip diameter between 2 and 4 gm were filled by capillarity with a 1
M sodium chloride solution prepared from filtered, distilled, deion-
ized water.
The micropipettes and the servo-null device were used to
measure the baseline interstitial fluid pressure (IFP) profiles in the
tumour as well as the pressure profiles generated by the low flow
rate infusions. A graded micromanipulator was used to insert
micropipettes at known depths from the tumour surface. The
pressure was measured for periods of 25-50 s, once a patent fluid
communication between the tissue and micropipette was estab-
lished. The following criteria were used to validate the measure-
ments: (a) the fluid communication between the micropipette and
the tissue was confirmed electrically, (b) the pressure remained
stable after varying the feedback gain of the system and (c) the
zero pressure in saline at the tumour surface did not change during
the measurements.
Experimental procedure
During fluid infusion into the tumour centre, there is a transient
redistribution offluid. This phenomenon is controlled by Kand the
Cofthe tissue. At steady state, the steepness ofthe pressure profile
around the infusion site is controlled by K only. Therefore, it is
possible to evaluate K by measuring the pressure profile generated
by the intratumoral infusion.
The mice were anaesthetized with ketamine/xylazine (90/
10 mg kg-'). During all procedures, mice were placed on a temper-
ature-regulated heating pad and the body temperature was main-
tained between 36°C and 37°C. To minimize the deformation of
the tumour during the insertion ofthe infusion needle, a small skin
incision was made. The insertion depth of the needle was
controlled by the moving arm of a graded micromanipulator.
Before the infusion, the baseline IFP in the tumour was measured
with micropipettes. To estimate K in LS174T, 5% albumin and
0.25% Evans blue in saline (0.9%) were infused at a rate of0.10 or
0.14 gl min-' with the infusion pump. Because of the low compli-
ance of HSTS 26T, infusions were made at a flow rate of
0.05 Rtl min-' in that tumour. The steady-state pressure profile
induced by the infusion needle was measured with micropipettes
(Figure 1B). With a reference mark on the infusion needle, the
micropipette was inserted close to the infusion source at an angle
of 450 with a graded micromanipulator under stereomicroscopic
British Journal of Cancer (1998) 78(11), 1442-1448 0 Cancer Research Campaign 19981444 YBoucher etal
Figure 2 Distribution of Evans-blue albumin in HSTS 26T and LS174T tumours after infusions at flow rates of 0.05 and 0.14 RImin-' respectively. A
Asymmetric distribution of Evans-blue in HSTS 26T. The infusion site is indicated by the arrowhead. The Evans blue has accumulated in two different regions,
close to the infusion site and at the tumour surface. A faint Evans blue streak (arrow) can be seen between the two principal regions of Evans blue accumulation
(magnification 9.0x). B Symmetrical distribution of Evans blue - albumin in the centre of a LS174T tumour. The infusion site (arrowhead) was located in the
centre of the Evans blue accumulation (magnification 9.0x)
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Figure 3 Typical pressure transients [P(a)] as monitored in the point source
needle, during intratumoral infusion in LS174T tumours Infusion at a
constant flow rate of 0.1 gl min1 was started at time t Radial pressure
profiles were measured when the pressure had leveled off(tj~. After stopping
the infusion (t.) the pressure decayed towards the baseline value. The soli,
lines represent the monoexponential curves (P(a)=P(a)±AP(a)[1 -exp(-t'.)])
from a least squares non-linear regression to the experimental data. Note
that the time constants of the increase and the decay in pressure were
similar (approximately 10 min)
guidance. The error in the radial position was ± 20 jm, as deter-
mined by the tip of the micropipette touching the tumour surface
before and after the measurements. The pressure was measured
within a distance of 0.3-2.0 mm from the edge of the infusion
cavity. Measurements were not obtained closer to the infusion
cavity, because the drop in pressure is very steep in that region. An
error in the radial position close to the source would, therefore,
lead to arelatively large error in the pressure profile. Furthermore,
the region close to the source is characterized by flow irregulari-
ties. To evaluate whether tumour blood vessels reabsorbed the
fluid infused, K was estimated after circulatory arrest by sacri-
ficing the animals.
Distribution of the Evans blue-albumin complex
The assumption of a spherical distribution of the infusion solution
was evaluated following the completion ofthe measurements. The
tumour was cut in the centre, and 2-3 mm anterior and posterior to
the fluid source.
Measurement of water content
To evaluate whether the infusion volume significantly modified
the water content in the tumour, we compared the water content of
tumours infused in vivo and tumours without infusion. After the
infusion of 8 ,ul of saline, a 3-mm-thick slice from the infusion
region was obtained from the centre of five tumours, and cut to
obtain apiece oftissue of3x3x3 mm. A similarpiece oftissue was
also obtained from the centre of five tumours that were not
infused. The wet weight (Tw) was measured immediately after
cutting. The dry weight (Td) was measured 24 and 48 h after
drying at 50°C. The tumour water content (T ) was calculated as
[(T -Td)/TW] x 100%.
Histology
At the end of the infusion, the animals were sacrificed. The leg
with the tumour was dissected from the animal, being careful not
to move the needle in the tumour. The tumours with the needle
were placed in fixative solution (formaldehyde 3.5%, methanol
1.5%) for 2-3 days. To examine the infused area, the tumour was
cut in half and two tissue slices (2 mm thick) were then obtained
from each side of the central cut. The tissue was processed for
histology and embedded in the plastic resin JB4. Tissue sections
(1-2 gm thick) were obtained and stained with toluidine blue.
Data analysis
K was estimated by applying Darcy's law for flow through a
porous medium (Baxter and Jain, 1989),
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normalized (viscosity 5% albumin in isotonic saline/viscosity
isotonic saline) at 20°C for comparison with literature values
(Levick, 1987). Furthermore, we estimated tissue compressibility
from the time constant of the pressure transients (Basser, 1992).
The time constant was obtained from a least squares non-linear
regression of a monoexponential function to the experimental data
P(a) =P(a), ± AP(a)[I-exp(-t/T)]
Average baseline pressure
(4)
where P(a), is the pressure in the infusion cavity, P(a), is the initial
pressure in the infusion cavity before a step change in flow rate
AP(a) is the difference in steady-state pressure and t is the charac-
teristic time constant. Compressibility was given by the following
formulation
0.4 0.8 1.2 1.6 2 2.4 2.8
Radial position (mm)
Figure 4 Typical radial pressure profiles measured during infusion at
0.1 gl min-1 into a LS174T xenograft. Two sequential measurements of
pressure were made at each spot. The radius of the infusion cavity (a) was
0.35 mm. The dotted line represents the average interstitial fluid pressure
measured before infusion. Errors in IFP and radial position were determined
from measurement of zero pressure on the surface and from the surface
coordinates respectively. The solid line represents the least squares non-
linear regression of the theoretical profile to the experimental data collected
during infusion. The theoretical profile used was P(r)=PO+(Q/4nK)[(1/r)-(1/R)].
The value of Kobtained in this tumour was 2.3x10-7 cm2/mmHg-1 s-1. Note
that the pressure measured in the infusion cavity was not included in the
determination of K
u = -KVp
T = [4 4 a2]I[n2 K] (5)
where 4 is the tissue compressibility; and a is the radius of the
infusion cavity. C was obtained from the product of 4 and the
tumour volume.
Statistical analysis
The data are given as the median and the range. Significant differ-
ences between two experimental groups were analysed with the
Mann-Whitney U-test. The relationship between parameters were
tested with a Spearman correlation.
(1) RESULTS
where u is the fluid velocity and Vp is the pressure gradient.
Based on the experimental data, the baseline IFP was considered
constant throughout the tumour. The radial steady-state pressure
profile during infusion was fitted for estimation of K using this
Darcy's law model
P(r) = PO + (Q/4itK)[(l/r)-(1/R)] (2)
where P(r), is the pressure at radial position r, P0 is the baseline
IFP, Q is the constant flow rate and R is the tumour radius. A
regional distribution of K was obtained from contiguous points in
the induced pressure gradients, using the differential form of the
theoretical profile.
K = (Q/47t)[(r2-r,)/r1r2][P(r,)-P(r2)] (3)
The mean radial position was taken as (r, + r2)/2. Only pressure
measurements which were 1 mmHg above the baseline plateau
pressure were included in the differential analysis. The values ofK
obtained were considered as average tissue K-values and were
To estimate K, we verified the assumption that spherically
symmetrical fluid flow occurred. After infusions, the tumours
were cut to evaluate the distribution of the Evans blue-albumin
complex. In HSTS 26T, the distribution of Evans blue was asym-
metric. The non-uniform distribution was observed in the region of
infusion or as a significant accumulation of Evans blue separated
from the infusion site (Figure 2A). Histological examination of
tumour slices revealed that in some tumours the accumulation of
Evans blue at some distance from the infusion site was associated
with necrotic regions. In other HSTS 26T tumours, the distribution
of Evans blue was associated with viable tumour tissue, and it
was impossible to characterize the causes of the asymmetric
distribution of the Evans blue-albumin complex. In contrast, in
LS174T tumours at flow rates of 0.1 or 0.14 tl min-' the dye
occupied, after approximately 90 min, a circular region of 2.5-
4.0 mm in the centre of most tumours, thus confirming the
assumption that spherically symmetrical fluid flow occurred
(Figure 2B). The main mode oftransport was, thus, bulk flow. The
Table 1 Estimates of K, compressibility and compliancea in colon adenocarcinoma LS174T tumours
Flow rate Kb Kc Time constant Compressibility Compliance
,ul min-' n (1O-7 cm2 mmHg-1 s-1) (10-7 Cm2 mmHg-1 s-1) (min) (10-1 mmHg-') (pI mmHg-')
In vivo 1.7d 1.7 9 2 35
0.1 8 (0.7-3.6)e (0.6-4.2) (7-18) (0.6-8) (12-230)
After CA 2.3 2.8 12 3 100
0.1 7 (1.7-3.9) (1.6-4.0) (7-19) (0.1-9) (20-235)
In vivo 3.1 3.2 6 2 55
0.14 4 (2.9-5.4) (2.6-5.8) (2-7) (0.7-4.5) (21-155)
aAll values are adjusted to flow of isotonic saline at 200C. bKestimate, based on a non-linear regression of all pressure data points to the theoretical pressure
profile. cKestimate, based on a differential analysis of contiguous pressure data points. dMedian. eRange.
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Figure 5 Radial distribution of Kbased on differential analysis of
contiguous points in the induced pressure gradient during constant flow rate
infusion at 0.1 ,u min-' in LS174T tumours. The formula used was:
K= (Q/4n)[(r2-r1)Ir,r2] [P(rl)-P(r2)]. The mean radial position was taken as
(rl+r2)/2. Note that, at this flow rate, neither in vivo (0; n = 8) nor after CA
(0; n = 7) do the data suggest any radial dependence of K
arrest. At a flow rate of 0.1 ,gl min-', by both types of analysis, the
median K-values were less in vivo compared with circulatory
arrest; however, the differences were not significant (Table 1).
If K was increased by the infusion (hydration of the tissue), the
effect could be more pronounced close to the source where the
pressure was higher. A linear regression of K (estimated by differ-
ential analysis) vs distance from the source showed no significant
differences in K-values in vivo (R2 = 0.09; P > 0.1) or after circula-
tory arrest (R2= 0.11; P>0.8) at a flow rate of 0.lOugl min-'
(Figure 5). The median water content in the central regions of
infused tumours was 83.4%, and 83.3% in tumours that were not
infused; the difference was not significant (P > 0.3). Histological
examination of the infusion area also suggested that the intratu-
moral infusion at low flow rates used in this study did not alter the
organization of the tissue. No pockets of fluid were found in the
immediate periphery of the hole left by the needle. The width of
the space between tumour cells was comparable in the proximity
and at some distance from the infusion cavity. At a flow rate of
0.10Il min-', K was apparently not affected by hydration.
However, K increased by 80% at a flow rate of 0.14 gl min-'
compared with 0.10 ugl min-' (Table 1).
DISCUSSION
diffusion coefficient (3 x 107 cm2 s-l) of albumin in LS174T
tumours (D Berk and RK Jain, unpublished data) cannot explain
the volume of penetration of the Evans blue-albumin complex.
Based on a length scale approximation ('4Dt where D is the diffu-
sion coefficient and t is time), albumin in the LS174T tumour
could penetrate by diffusion approximately 0.8 mm in 90 min. The
data collected in HSTS 26T were not included in the analysis for K
and C because of the asymmetric fluid distribution.
In previous studies, we have shown that the baseline IFP
throughout a tumour is quasi-uniform, except for a sharp pressure
drop in the tumour periphery (Boucher et al, 1990; Boucher and
Jain, 1992). In the LS174T tumour, the IFP was also uniform in the
centre and dropped close to the surface. The median tumour IFP
in vivo was 14.0 mmHg (range 7-23.5). The placement of the
infusion needle in the tumour did not modify the steady-state IFP
profiles. Figure 3 shows typical changes in the infusion needle pres-
sure in a tumour during infusion in vivo, at a rate of0.10 ,ul min-'.
The infusion pressure reached steady state within 25-60 min, with
a time constant of 7-18 min. The pressure profile induced by the
infusion was measured at steady state (Figure 4). At 0.3-0.5 mm
from the infusion source, the pressure measured with micropipettes
was 3-12 mmHg higher than the baseline IFP in the tumour before
the infusion. The pressure dropped to the baseline IFP value in the
tumours within a radius of 1-2 mm from the source.
In LS174T, at a flow rate of 0.1 p1l min-', median K in vivo was
1.7 x 10-7 cm2 mmHg-' s, both by differential analysis and by least
squares non-linear regression of the theoretical profile to the
measured pressure profile. After circulatory arrest, median K by
differential analysis was 2.8 x 10-' and from a fit to the complete
profile 2.3 x 10-7 (Table 1). No significant differences were found
by estimating K by differential analysis or by fitting the complete
profile (Table 1). Because ofthe high hydraulic permeability ofthe
tumour vasculature (Sevick and Jain, 1991), we expected that the
fluid infused would be reabsorbed in part by the blood vessels, thus
the estimate of K in vivo could be an overestimate. To evaluate
whether fluid was reabsorbed, K was measured after circulatory
K has been measured with in vitro and in vivo techniques. Two
approaches are used to measure K in vitro: the measurement of
fluid extrusion from tissue under compression or by applying a
pressure head across a tissue slice of known thickness. With in
vitro techniques, the influence of compression and hydration on
the measurements ofK have to be considered (Levick, 1987). K in
vivo is obtained from the measurement of fluid velocity resulting
from a natural or an applied pressure gradient (Guyton et al, 1966;
Swabb et al, 1974; Levick, 1979; DiResta et al, 1993). Most in
vivo measurements of K are limited by the poor definition of
geometric dimensions and by difficulties in separating K from C.
The present technique measures with micropipettes the radial pres-
sure profile generated by a constant-flow infusion. The resolution
provided by micropipettes permits precise determinations of the
distance between the infusion source and the tip of the
micropipette. Measurements ofKin vivo or after circulatory arrest
are made at steady state, the contribution of C is, thus, negligible.
K can be measured by differential analysis at different radial posi-
tions from the infusion needle or by fitting the complete pressure
profile. Because the technique is dependent on the spherically
symmetrical distribution ofthe fluid infused, heterogeneity in fluid
flow limits the determination of K (e.g. HSTS 26T tumour).
Potentially, Kcould be estimated from the pressure in the infusion
needle. This estimation would be less accurate because it is not
possible to determine precisely the size ofthe cavity (needle radius
+ tissue displacement). A small error in the estimation of this
dimension would lead to a big error in the K estimation.
A potential limitation ofthe present and also ofprevious in vivo
techniques estimating K is the possibility that the fluid infused
could be reabsorbed by blood or lymphatic vessels (Guyton et al,
1966; Levick, 1980). We addressed the issue of reabsorption by
estimating K in vivo and after circulatory arrest. Mellander (1960)
demonstrated that fluid reabsorption in the hind limb microcircula-
tion ceased completely within 1 min of circulatory arrest. Recent
data suggest that this is also the case in tumours (Netti et al, 1995).
We found in the LS174T tumour similar values of K in vivo and
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after circulatory arrest, thus suggesting that reabsorption of the
fluid infused is minimal or zero in the LS174T tumour. A possible
reason why reabsorption was not significant in vivo could be
because of local properties in the region of the infusion. The infu-
sions were done in the tumour centre. Generally, vascular density
and blood flow in experimental tumours are reduced in the centre
compared with peripheral regions (Thompson et al, 1987; Jirtle,
1988; Tozer et al, 1990). However, in the region surrounding the
infusion needle, blood vessels were observed on histological
slides. In some cases, the blood vessels appeared congested with
red blood cells suggesting a stagnant flow. If blood perfusion was
stopped in the vicinity of the needle, reabsorption would be
minimal and most of the fluid would be transported by bulk flow
through the interstitial matrix. The fact that K-values were similar
in vivo and after circulatory arrest in LS174T tumours demon-
strates that K can be measured in two different types of prepara-
tions without being modified. However, this cannot be a general
rule, it is possible that in other tumour types K estimates could be
significantly different in vivo and after circulatory arrest. If K is
estimated in vivo, it should also be measured after circulatory
arrest to determine whether reabsorption is significant.
Several studies have shown that K is modified by tissue hydra-
tion (Guyton et al, 1966; Fatt, 1968; Zawieja et al, 1992). At a flow
rate of0.10 tl min-, we did not detect any influence ofthe infusion
on K. No significant differences in water content could be found
between infused and non-infused tumour tissue. We speculated that
hydration and Kcould be higher when closer to the infusion needle.
However, K estimated by differential analysis did not change with
distance from the source. At a constant flow of0.14 ,tl min-', Kwas
80% higher than at a flow of 0.10 Itl min-'. This increase might be
due to reabsorption or hydration. Reabsorption was probably not
playing a majorrole, because the pressures induced at infusion rates
of0.10 and 0.14 Rl min-' were similar.
In normal tissues, K-values span four orders of magnitude. High
K-values have been measured in lung tissue and vitreous body, and
lower K-values have been found for cartilage, corneal stroma and
subcutaneous tissue (Levick, 1987; Lai Fook et al, 1989). Swabb
et al (1974) reported the first measurements ofKfor tumour tissue,
K in vitro for a slice of rat hepatoma (0.3 x 107 cm2/mmHg/s) was
fivefold higher than in normal subcutaneous tissue. Our in vivo
values of K (1.7 x 10-7) for the colon adenocarcinoma LS174T are
almost sixfold higher than K for slices of rat hepatoma. In another
study with the same tumour (LS174T), we found that K in vitro
(2.4 x 10-7cm2/mmHg/s) measured with a flow chamber was
comparable to the present in vivo values (C Znati, Y Boucher and
RKJain, unpublished data). Swabb et al (1974) also estimated Kin
vivo by measuring the unsteady flow from micropore chambers
embedded in a subcutaneous tumour, and reported values that were
tenfold lower than their in vitro values. Because ofthe uncertainty
in the calculations to obtain K, it is possible that their in vivo
values were not accurate, as acknowledged by Swabb et al (1974).
In a recent study, DiResta et al (1993) calculated from IFP gradi-
ents and bulk flow measurements a K-value of 59xlO-7 cm2/
mmHg/s in a human neuroblastoma transplanted into immuno-
deficient animals.
Estimation of C and implication for estimation of Lp
By estimating K in vivo at steady state with the present technology,
it would be possible to estimate other fluid transport parameters.
The transient evolution of the infusion pressure (Figure 3) is
controlled by the product of C and K (Ford et al, 1991; Basser,
1992). From the estimate of the time constant of this evolution
and K, it is possible to estimate compressibility and C (Table 1).
Because these measurements of compressibility and C are highly
dependent on the assumptions and the formulation used to calculate
them, they have to be considered as first order approximations. A
better estimate could be provided by a proper mathematical model
that would describe more accurately the transient phenomena.
The steepness of the baseline IFP profiles in tumours can be
defined by the parameter oc& (Jain and Baxter, 1988; Baxter and
Jain, 1989).
OC2= R2 (L IK) (S/V)
where R is the tumour radius, Lp the vascular hydraulic conduc-
tivity and S/V surface area per unit tissue volume for transcapillary
exchange. By knowing K and obtaining &2 from measurements of
peripheral IFP profiles, Lp could also be estimated. The accuracy
ofLp determination will be dependent on careful estimates of SIV
and K.
Implications for systemic and intratumoral delivery of
therapeutic agents
The tissue hydraulic conductivity (K) is a key determinant of the
systemic and intratumoral delivery of therapeutic agents. A rela-
tively low K can contribute to the elevated IFP which has been
associated with the poor accumulation of macromolecules (e.g.
monoclonal antibodies) in tumours (Sands, 1992; Jain, 1993). We
previously demonstrated that the IFP profiles in experimental
tumours were uniform throughout the tumour and dropped steeply
in the periphery (Boucher et al, 1990). In a mathematical model for
fluid transport in solid tumours, the ratio ofLpIK was identified as
a determinant ofthe steepness ofthe IFP profiles (Jain and Baxter,
1988; Baxter and Jain, 1989). In a subsequent study, we found that
the superficial microvascular pressure was similar to the central
IFP, whereas in the tumour periphery the microvascular pressure
was significantly higher than the IFP (Boucher and Jain, 1992).
The IFP distribution in tumours suggests that fluid filtration is
negligible in the centre and high in the periphery. Because extrava-
sation of macromolecules and filtration of fluids are potentially
coupled, this could explain the poor accumulation of macromole-
cules in the central areas oftumours (Jain and Baxter, 1988; Baxter
and Jain, 1989). A large increase in K could reduce the IFP in the
centre oftumours and, thus, increase the filtration offluids and the
extravasation of macromolecules.
To improve the penetration of monoclonal antibodies, gene
vectors and other therapeutic agents in normal or tumour tissues,
interstitial infusion methods have been developed (Bobo et al,
1994; Morrison et al, 1994; Order et al, 1994) The present tech-
nique is able to characterize key determinants (K, compliance,
pressure gradients and reabsorption) that will influence the success
ofintratumoral infusions. IfKis elevated, a uniform distribution of
the infused drug throughout the tumour would be expected.
However, if K is very low, the enhancement provided by intratu-
moral infusion may be less. As K decreases the volume of tissue
penetrated by fluid will reduce to a small region around the infu-
sion source. Heterogeneity in K or in compliance could result in
the asymmetric distribution of therapeutic agents or other mole-
cules that are infused into the tumour. Significant differences in the
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distribution of Evans blue-albumin were found between HSTS
26T and LS174T tumours. In general, in LS174T tumours the
distribution of Evans blue-albumin was uniform, whereas in
HSTS 26T tumours the distribution was asymmetric. The asym-
metric distribution of Evans blue-albumin in HSTS 26T tumours
was observed in viable and necrotic regions. Large deposits of
Evans-blue were associated with necrotic regions at distance from
the infusion site, thus suggesting that necrotic areas could repre-
sent preferential pathways (higher K) and sinks for the accumula-
tion of therapeutic agents (Figure 2A). The non-uniform
distribution of therapeutic agents could significantly limit the
success ofintratumoral infusions.
To increase K, enzymatic degradation of the interstitial matrix
could be used. Degradation of the matrix with hyaluronidase
increased Kby ten-to 20-fold in muscle fascia (Day, 1952), and by
a factor of 24 in the lung (Lai Fook et al, 1989). In a preliminary
study, we measured K in vivo in two tumours following the intra-
tumoral infusion (0.1 tl min-') ofhyaluronidase. By least squares
non-linear regression of the measured pressure profile, the values
were 7.7 x 107 and 11.0 x 107 cm2/mmHg-' s. These two values
are greater than the maximum values of K in the control group
(Table 1). Further studies are needed to evaluate the effect of
enzyme digestion on Kand on the IFP profiles in solid tumours.
In conclusion, we have developed a new technique to estimate K
in vivo and after circulatory arrest in tumours with a spherically
symmetrical distribution of the fluid infused. The precise spatial
resolution of the micropipette technique provides a significant
advantage over other techniques for estimating K in vivo. Most
importantly the technique can be used to measure and manipulate
fluid transport parameters in tumours to improve the delivery of
therapeutic agents.
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